Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice

Blood

Volumn 109, Issue 3, 2007, Pages 1043-1050

  Wai, Hon Lim ^a,b   Kireta, Svjetlana ^a   Russ, Graeme Randolph ^a,b   Coates, Patrick Toby Hewlett ^a,b,c  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c Queen Elizabeth Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CHLOROQUINE; CPG OLIGODEOXYNUCLEOTIDE; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INTERACTION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EPSTEIN BARR VIRUS; FEMALE; IMMUNE RESPONSE; IMMUNOREGULATION; LOG RANK TEST; LYMPHOPROLIFERATIVE DISEASE; MALE; MORTALITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; NONOBESE DIABETIC MOUSE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA CELL; PRIORITY JOURNAL; SCID MOUSE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; T LYMPHOCYTE; VIRUS IMMUNITY; VIRUS INFECTION;

EID: 33846878526     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-12-024802     Document Type: Article

References (55)

1. Fleisher G, Henle W, Henle G, Lennette E, Biggar R. Primary infection with Epstein-Barr virus in infants in the United States: clinical and serologic observations. J Infect Dis. 1979;139:553-558.
2. Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000;343:481-492.
3. Garnier J, Berger F, Betual H. Epstein-Barr virus associated lymphoproliferative diseases (B cell lymphoma) after transplantation. Nephrol Dial Transplant. 1989;4:818-823.
4. Ho M. Risk factors and pathogenesis of posttransplant lymphoproliferative disorders. Transplant Proc. 1995;27:38-40.
5. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Ann Rev Immunol. 2000;18:767-811.
6. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-251.
7. Coates PTH, Thomson AW. Dendritic cells, tolerance induction and transplant outcome. Am J Transplant. 2002;2:299-307.
8. Robinson S, Patterson S, English N, Davies D, Knight S, Reid C. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol. 1999;29:2769-2775.
9. Liu Y, Kanzler H, Soumelis V, Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol. 2001;2:585-589.
10. Liu YJ. IPC: professional type I interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol. 2005;23:275-306.
11. Dzionek A, Fuchs A, Schmidt P, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000;165:6037-6046.
12. Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol. 2001;31:3388-3393.
13. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med. 2003;198:513-520.
14. + dendritic cells. J Immunol. 2001;166:5000-5007.
15. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent Th1 polarization. Nat Immunol. 2000;1:305-310.
16. Murphy WJ, Taub D, Longo D. The huPBL-SCID mouse as a means to examine human immune function in vivo. Semin Immunol. 1996;8:233-241.
17. Shultz L, Schweitzer PA, Christianson SW, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-Sicd mice. J Immunol. 1995;154:180-191.
18. Lim WH, Kireta S, Russ GR, Coates PTH. Renal transplantation reverses functional deficiencies in circulating dendritic cell subsets in chronic renal failure patients. Transplantation. 2006;81:160-168.
19. Jinushi M. Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J Immunol. 2003;171:5423-5429.
20. Nalesnik MA. The diverse pathology of posttransplant lymphoproliferative disorders: the importance of a standardized approach. Transpl Infect Dis. 2001;3:88-96.
21. Mailliard R, Son Y, Redlinger R, et al. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol. 2003;171:2366-2373.
22. Hackstein H, Renner F, Bohnert A, et al. Dendritic cell deficiency in the blood of kidney transplant patients on long-term immunosuppression: results of a prospective matched-cohort study. Am J Transplant. 2005;5:2945-2953.
23. Athanassopoulos P, Vaessen L, Maat A, Balk A, Weimar W, Bogers A. Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responses. Eur J Cardiothorac Surg. 2004;25:619-626.
24. + lymphoproliferative disease in hu PBL-SCID mice. Blood. 2005;105:1558-1565.
25. Williams H, McAulay K, Macsween K, et al. The immune response to primary EBV infection: a role for natural killer cells. Br J Haematol. 2005;129:266-274.
26. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev. 2001;14:778-809.
27. Le Bon A, Schiavoni G, D'Agostinio G, Gresser I, Belardelli F, Tough D. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity. 2001;14:461-470.
28. Salazar-Mather T, Ishikawa R, Biron C. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. J Immunol. 1996;157:3054-3064.
29. Agarwala S, Kirkwood J. Update on the role of adjuvant interferon for high risk melanoma. Forum (Genova). 2000;10:230.
30. Davis C, Wood B, Sabath D, Joseph J, Stehman-Breen C, Broudy V. Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplant. Transplantation. 1998;66:1770-1779.
31. Hochrein H, Schlatter B, O'Keeffe M, et al. Herpes-simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and independent pathways. Proc Natl Acad Sci U S A. 2004;101:11416-11421.
32. Gary-Gouy H, Lebon P, Dalloul A. Type I interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines. J Interferon Cytokine Res. 2002;22:653-659.
33. Moore K, Vieira P, Fiorentino D, Trounstine M, Khan T, Mosmann T. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science. 1990;248:1230-1234.
34. Baiocchi O, Colleoni G, Caballero O, et al. Epstein-Barr viral load, interleukin-6 and interleukin-10 levels in post-transplant lymphoproliferative disease: a nested case-control study in a renal transplant cohort. Leuk Lymphoma. 2005;46:533-539.
35. Muti G, Klersy C, Baldanti F, et al, Cooperative Study Group on PTLDs. Epstein-Barr virus (EBV) load and interleukin-10 in EBV-positive and EBV-negative post-transplant lymphoproliferative disorders. Br J Haematol. 2003;122:927-933.
36. Klenerman P, Hill A. T cells and viral persistence: lessons from diverse infections. Nat Immunol. 2005;6:873-879.
37. Shedlock D, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science. 2003;300:337-339.
38. + T lymphocytes. Nature. 2003;421:852-856.
39. Biron C, Nguyen K, Pien G, Cousens L, Salazar-Mather T. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol. 1999;17:189-220.
40. hi T regulatory cells. Eur J Immunol. 2005;35:2452-2458.
41. Gerosa F, Gobbi A, Zorzi P, et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol. 2005;174:727-734.
42. Siren J, Sareneva T, Pirhonen J, et al. Cytokine and contact-dependent activation of natural killer cells by influenza A or Sendai virus-infected macrophages. J Gen Virol. 2004;85:2357-2364.
43. Matikainen S, Paananen A, Miettinen M, et al. IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12. Eur J Immunol. 2001;31:2236-2245.
44. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med. 2002;195:327-333.
45. Mocellin S, Panelli M, Wang E, et al. IL-10 stimulatory effects on human NK cells explored by gene profile analysis. Genes Immun. 2004;5:621-630.
46. Qian C, Jiang X, An H, et al. TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs) leading to NK cell activation. Blood. 2006;108:2307-2315.
47. Megjugorac N, Young H, Amrute S, Olshalsky S, Fitzgerald-Bocarsly P. Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells. J Leuk Biol. 2004;75:504-514.
48. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004;5:987-995.
49. Matsumoto M. Subcellular localization of toll-like receptor 3 in human dendritic cells. J Immunol. 2003;171:3154-3162.
50. Kadowaki N, Ho S, Antonenko S, et al. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J Exp Med. 2001;194:863-869.
51. Popescu I, Macedo C, Zeevi A, et al. Ex vivo priming of naive T cells into EBV-specific Th1/Tc1 effector cells by mature autologous DC loaded with apoptotic/necrotic LCL. Am J Transplant. 2003;3:1369-1377.
52. + cytotoxic T cells from virus naive individuals. J Immunol. 2002;168:909-918.
53. Lim W, Russ G, Coates PTH. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Nephrology. 2006;11:355-366.
54. Arpinati M, Green C, Heimfeld S, Heuser J, Anasetti C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood. 2000;95:2484-2490.
55. Maraskovsky E, Daro E, Rous E, et al. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood. 2000;96:878-885.